{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T18:22:48Z","timestamp":1778610168994,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.leukres.2009.10.004","type":"journal-article","created":{"date-parts":[[2009,11,4]],"date-time":"2009-11-04T09:56:06Z","timestamp":1257328566000},"page":"649-657","source":"Crossref","is-referenced-by-count":36,"title":["Different susceptibilities to 1,25-dihydroxyvitamin D3-induced differentiation of AML cells carrying various mutations"],"prefix":"10.1016","volume":"34","author":[{"given":"El\u017cbieta","family":"Gocek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Kie\u0142bi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Baurska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Haus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Kutner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Marcinkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.10.004_bib1","doi-asserted-by":"crossref","unstructured":"Hamadani M, Awan FT. Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia. Hematol Oncol; 2009 [Epub ahead of print].","DOI":"10.1002\/hon.915"},{"key":"10.1016\/j.leukres.2009.10.004_bib2","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1073\/pnas.77.5.2936","article-title":"Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid","volume":"77","author":"Breitman","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2009.10.004_bib3","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1073\/pnas.78.8.4990","article-title":"Differentiation of mouse myeloid leukemia cells induced by 1-alpha,25-dihydroxyvitamin D3","volume":"78","author":"be","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2009.10.004_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0145-2126(83)90057-7","article-title":"1,25-Dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal bone marrow cells","volume":"7","author":"McCarthy","year":"1983","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2009.10.004_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","author":"Huang","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsbmb.2005.06.017","article-title":"Vitamin D compounds in leukemia","volume":"97","author":"Luong","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.leukres.2009.10.004_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0145-2126(94)00061-E","article-title":"Expression of cell surface antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3, retinoic acid and DMSO","volume":"19","author":"Brackman","year":"1995","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2009.10.004_bib8","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2008-04-150250","article-title":"Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"113","author":"Sanz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib9","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.leukres.2009.10.004_bib10","first-page":"200","article-title":"Structure\u2013function relationships in the vitamin D endocrine system","volume":"16","author":"Bouillion","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.leukres.2009.10.004_bib11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1517\/13543770902877717","article-title":"Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands","volume":"19","author":"Choi","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.leukres.2009.10.004_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/TCRM.S1478","article-title":"Calcipotriol\/betamethasone dipropionate in the treatment of psoriasis vulgaris","author":"Vakirlis","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.leukres.2009.10.004_bib13","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1185\/03007990902844097","article-title":"Chronic kidney disease Markov model comparing paricalcitol to calcitriol for secondary hyperparathyroidism: a US perspective","volume":"25","author":"Nuijten","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.leukres.2009.10.004_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1073\/pnas.80.1.201","article-title":"1-Alpha,25-dihydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells","volume":"80","author":"Honma","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2009.10.004_bib15","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-04-2800","article-title":"19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia","volume":"65","author":"Kumagai","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2009.10.004_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jsbmb.2008.09.012","article-title":"Novel Gemini vitamin D3 analogs have potent antitumor activity","volume":"112","author":"Saito","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.leukres.2009.10.004_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000163849","article-title":"Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia","volume":"75","author":"Shabtay","year":"2008","journal-title":"Oncology"},{"key":"10.1016\/j.leukres.2009.10.004_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(84)92676-X","article-title":"Treatment of advanced myelodysplastic syndrome with alfacalcidol","author":"Mehta","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2009.10.004_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajh.2830380112","article-title":"The effect of 1-hydroxyvitamin D3 for prolongation of leukemic transformation-free survival in myelodysplastic syndromes","volume":"38","author":"Motomura","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2009.10.004_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.leukres.2005.04.003","article-title":"D2 analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome","volume":"29","author":"Koeffler","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2009.10.004_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French\u2013American\u2013British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2009.10.004_bib22","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsbmb.2005.06.010","article-title":"The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C\/EBP pathway","volume":"97","author":"Studzinski","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.leukres.2009.10.004_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/CAD.0b013e3280143166","article-title":"Antitumor properties of diastereomeric and geometric analogs of vitamin D3","volume":"18","author":"Wietrzyk","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.leukres.2009.10.004_bib25","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.febslet.2007.03.055","article-title":"Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation","volume":"581","author":"Gocek","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.leukres.2009.10.004_bib26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4161\/cc.1.6.269","article-title":"Derivatives of vitamins D2 and D3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells","volume":"1","author":"Ji","year":"2002","journal-title":"Cell Cycle"},{"key":"10.1016\/j.leukres.2009.10.004_bib27","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.steroids.2008.06.010","article-title":"Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential","volume":"73","author":"Gocek","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.leukres.2009.10.004_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0960-0760(98)00065-X","article-title":"Cell differentiating and anti-proliferative activity of side-chain modified analogues of 1,25-dihydroxyvitamin D3","volume":"67","author":"Marcinkowska","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.leukres.2009.10.004_bib29","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1182\/blood.V90.7.2591","article-title":"A novel, myeloid transcription factor, C\/EBPepsilon, is upregulated during granulocytic, but not monocytic, differentiation","volume":"90","author":"Morosetti","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib30","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood.V77.5.1080.1080","article-title":"NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)","volume":"77","author":"Lanotte","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.2910260208","article-title":"Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)","volume":"26","author":"Tsuchiya","year":"1980","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2009.10.004_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ijc.2910170504","article-title":"Establishment and characterization of a human histiocytic lymphoma cell line (U-937)","volume":"17","author":"Sundstr\u00f6m","year":"1976","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2009.10.004_bib33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/jcb.20787","article-title":"1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS\/RAF\/ERK-MAP kinase signalling pathway","volume":"98","author":"Hughes","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.leukres.2009.10.004_bib34","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.biocel.2004.12.005","article-title":"FLT-3: a new focus in the understanding of acute leukemia","volume":"37","author":"Markovic","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.leukres.2009.10.004_bib35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2009.10.004_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2004-07-2942","article-title":"AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations","volume":"106","author":"Choudhary","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2141.2001.02523.x","article-title":"Sensitization by 5-aza-2\u2032-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25-dihydroxyvitamin D3","volume":"112","author":"Niitsu","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2009.10.004_bib38","series-title":"Tumours of haematopoietic and lymphoid tissues (World Health Organization classification of tumours)","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.leukres.2009.10.004_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1182\/blood.V97.1.89","article-title":"Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia","volume":"97","author":"Meshinchi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib40","first-page":"595","article-title":"Hematopoietic receptors of class III receptor-type tyrosine kinases","volume":"4","author":"Rosnet","year":"1993","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.leukres.2009.10.004_bib41","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood.V98.2.328","article-title":"Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells","volume":"98","author":"Zeng","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib42","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood.V95.11.3489","article-title":"Mice lacking Flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells","volume":"95","author":"McKenna","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib43","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.leu.2400812","article-title":"Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines","volume":"11","author":"Yokota","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.10.004_bib44","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/sj.leu.2403790","article-title":"Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group","volume":"19","author":"Callens","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.10.004_bib45","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood.V97.8.2434","article-title":"Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies","volume":"97","author":"Yamamoto","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib46","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood-2003-02-0418","article-title":"FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy","volume":"103","author":"Taketani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib47","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood-2004-02-0754","article-title":"Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation","volume":"104","author":"Christiansen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.10.004_bib48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1081\/CNV-120018821","article-title":"AML1 interconnected pathways of leukemogenesis","volume":"21","author":"Michaud","year":"2003","journal-title":"Cancer Invest"},{"key":"10.1016\/j.leukres.2009.10.004_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.leu.2402766","article-title":"New mechanisms of AML1 gene alteration in hematological malignancies","volume":"17","author":"Roumier","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.10.004_bib50","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1080\/10428190802311383","article-title":"Laboratory study of a complex translocation t(2;8;21) (p12;q22;q22) in a patient with acute myelogenous leukemia","volume":"49","author":"Zhang","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2009.10.004_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0165-4608(96)00363-9","article-title":"Regional cancer cytogenetics: a report on 1,143 diagnostic cases","volume":"96","author":"Perkins","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2009.10.004_bib52","first-page":"401","article-title":"Cytogenetic analysis and clinical significance of chromosome 7 aberrations in acute leukaemia","volume":"44","author":"Brozek","year":"2003","journal-title":"J Appl Genet"},{"key":"10.1016\/j.leukres.2009.10.004_bib53","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.leu.2400706","article-title":"Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia","volume":"11","author":"El-Rifai","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.10.004_bib54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/gcc.2870080402","article-title":"Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci","volume":"8","author":"Johansson","year":"1993","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2009.10.004_bib55","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/clinchem\/46.8.1252","article-title":"Multifaceted approach to the diagnosis and classification of acute leukemias","volume":"46","author":"McKenna","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.leukres.2009.10.004_bib56","first-page":"1","article-title":"Tacalcitol ointment for the treatment of nail psoriasis","volume":"1","author":"Marquez Balbas","year":"2009","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.leukres.2009.10.004_bib57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2133.2008.08906.x","article-title":"Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo","volume":"160","author":"Rodr\u00edguez-Mart\u00edn","year":"2009","journal-title":"Br J Dermatol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609004974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609004974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T12:02:14Z","timestamp":1590235334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609004974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0145212609004974"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.10.004","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}